1. Mussetti A, Peric Z, Figueroa C. COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US. Current Opinion in Infectious Diseases. 2022; 35(4): 295-01. DOI: 10.1097/qco.0000000000000843
2. Шешунова Р.А. Формирование и развитие гематологической службы в России. Наука и инновации в медицине. - 2019. - Т. 4. - №1. - С.42-47.
3. Лукина К.А., Зайцев Д.А., Гармаева Т.Ц., Менделеева Л.П. Телемедицина как инструмент межрегионального дистанционного взаимодействия с профильными медицинскими организациями субъектов Российской Федерации: 5-летний опыт ФГБУ “НМИЦ гематологии” Минздрава России // Врач и информационные технологии. - 2020. - №4. - С.68-77.
4. Лагутин М.Д., Самофалов Д.А., Тюфилин Д.С., Чигрина В.П., Кильник А.И., Кобякова О.С. Тренды в оказании телемедицинских услуг ведущими федеральными центрами Российской Федерации. Социальные аспекты здоровья населения сетевое издание. - 2024. - Т.70. - №2. - С.1. Режим доступа: http://vestnik.mednet.ru/content/view/1581/27/lang,ru/.
5. Иванова А.А., Завалева Е.В., Павлюк А.В., Новичкова Г.А. Возможности, проблемы и перспективы применения телемедицинских технологий в области детской онкогематологии // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. - 2020. - Т.19. - №3. - С.189-193.
6. Федеральный закон от 21 ноября 2011 года №323-ФЗ “Об основах охраны здоровья граждан в Российской Федерации”. Доступно по: https://minzdrav.gov.ru/documents/7025-federalnyy-zakon-ot-21-noyabrya-2011-g-323-fz-ob-osnovah-ohrany-zdorovya-grazhdan-v-rossiyskoy-federatsii.
7. Shah AC, O’Dwyer LC, Badawy SM. Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies. JMIR Mhealth Uhealth. 2021; 9(7): e29619. DOI: 10.2196/29619
8. Jacobsen M, Rottmann P, Dembek TA et al. Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies. JCO Clinical Cancer Informatics. 2022; 6. DOI: 10.1200/CCI.21.00126
9. Nawas MT, Landau HJ, Sauter CS et al. Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantatio. 2020; 26(6): e135-7. DOI: 10.1016/j.bbmt.2020.02.004
10. Chang E, Iukuridze A, Echevarria M, et al. Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular Disease. Biology of Blood and Marrow Transplantation. 2020; 26(6): 1233-7. DOI: 10.1016/j.bbmt.2020.02.027
11. Turner J, He Q, Baker K, et al. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease. Transplantation and Cellular Therapy. 2021; 27(7): 616.e1-616.e6. DOI: 10.1016/j.jtct.2021.03.024
12. Postorino M, Treglia M, Giammatteo J, et al. Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome. Int J Environ Res Public Health. 2020; 17(23): 8834. DOI: 10.3390/ijerph17238834
13. Palandri F, Bartoletti D, Giaquinta S, et al. Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction. British Journal of Haematology. 2020; 192(2). DOI: 10.1111/bjh.17208
14. Darcourt JG, Aparicio K, Dorsey PM et al. Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic. JCO Oncology Practice. 2021; 17(1): e36-43. DOI: 10.1200/op.20.00572
15. Kumar P, Aggarwal M, Dhawan R, et al. Tele-Medicine Services in Hematological Practice During Covid Pandemic: Its Feasibility and Difficulties. Indian Journal of Hematology and Blood Transfusion. 2020; 37(4): 528-33. DOI: 10.1007/s12288-020-01385-7
16. Mussetti A, Salas MQ, Condom M, et al. Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study. JMIR Formative Research. 2021; 5(3): e26121. DOI: 10.2196/26121
17. Lupo-Stanghellini MT, Messina C, Marktel S, et al. Following-up allogeneic transplantation recipients during the COVID-19 pandemic. The Lancet Haematology. 2020; 7(8): e564-5. DOI: 10.1016/s2352-3026(20)30176-9
18. Paludo J, Bansal R, Holland AT, et al. Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell Therapy. Blood. 2021; 138(S1): 568-568. DOI: 10.1182/blood-2021-149103